These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30613369)

  • 1. Correction: Cutaneous melanoma primary site is linked to nevus density.
    Martin-Gorgojo A; Llinares M; Virós A; Requena C; Garcia-Casado Z; Traves V; Kumar R; Nagore E
    Oncotarget; 2018 Dec; 9(95):36816. PubMed ID: 30613369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma.
    Alon M; Arafeh R; Lee JS; Madan S; Kalaora S; Nagler A; Abgarian T; Greenberg P; Ruppin E; Samuels Y
    Oncotarget; 2019 Feb; 10(13):1344. PubMed ID: 30863494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells.
    Romano E; Rufo N; Korf H; Mathieu C; Garg AD; Agostinis P
    Oncotarget; 2018 Dec; 9(97):37076. PubMed ID: 30651937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth.
    Hanson K; Robinson SD; Al-Yousuf K; Hendry AE; Sexton DW; Sherwood V; Wheeler GN
    Oncotarget; 2018 Nov; 9(93):36645. PubMed ID: 30564304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma.
    Bjoern J; Lyngaa R; Andersen R; Hölmich LR; Hadrup SR; Donia M; Svane IM
    Oncotarget; 2018 Nov; 9(88):35870. PubMed ID: 30533201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma.
    Hu K; Babapoor-Farrokhran S; Rodrigues M; Deshpande M; Puchner B; Kashiwabuchi F; Hassan SJ; Asnaghi L; Handa JT; Merbs S; Eberhart CG; Semenza GL; Montaner S; Sodhi A
    Oncotarget; 2021 Mar; 12(5):519-520. PubMed ID: 33747364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis.
    Marciel MP; Khadka VS; Deng Y; Kilicaslan P; Pham A; Bertino P; Lee K; Chen S; Glibetic N; Hoffmann FW; Matter ML; Hoffmann PR
    Oncotarget; 2018 Jul; 9(56):30937. PubMed ID: 30112120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The familial occurrence of cutaneous melanoma, intraocular melanoma, and the dysplastic nevus syndrome.
    Greene MH; Sanders RJ; Chu FC; Clark WH; Elder DE; Cogan DG
    Am J Ophthalmol; 1983 Aug; 96(2):238-45. PubMed ID: 6881247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blue Nevus-Like Metastasis of a Cutaneous Melanoma Identified by Fluorescence In Situ Hybridization.
    Campa M; Patel M; Aubert P; Hosler G; Witheiler D
    Am J Dermatopathol; 2016 Sep; 38(9):695-7. PubMed ID: 27097332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes.
    Hakkim FL; Bakshi HA; Khan S; Nasef MM; Farzand R; Sam S; Rashan L; Al-Baloshi MS; Abdo Hasson SSA; Jabri AA; McCarron PA; Tambuwala MM
    Oncotarget; 2020 Jun; 11(23):2259-2261. PubMed ID: 32577169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Blood transcriptional profiling reveals IL-1 and integrin signaling pathways associated with clinical response to extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma.
    Ying Z; Shiue L; Park K; Kollet J; Bijani P; Goswami M; Duvic M; Ni X
    Oncotarget; 2019 Sep; 10(52):5492. PubMed ID: 31534633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Black and Brown Oro-facial Mucocutaneous Neoplasms.
    Natarajan E
    Head Neck Pathol; 2019 Mar; 13(1):56-70. PubMed ID: 30693458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of immunohistochemical staining of PRAME in differential diagnosis between melanoma and melanocytic nevus].
    Du J; Yu WJ; Guo RP; Su J
    Zhonghua Bing Li Xue Za Zhi; 2022 Jul; 51(7):621-626. PubMed ID: 35785832
    [No Abstract]   [Full Text] [Related]  

  • 15. Correction: Hereditary cutaneous malignant melanoma-dysplastic nevus.
    Hodge SE; Bale SJ; Goldstein AM; Tucker MA
    N Engl J Med; 1991 Mar; 324(13):925. PubMed ID: 2000119
    [No Abstract]   [Full Text] [Related]  

  • 16. Melanocytes of a melanocytic nevus in a lymph node from a patient with a primary cutaneous melanoma associated with a small congenital nevus.
    Hruban RH; Eckert F; Baricević B
    Am J Dermatopathol; 1990 Aug; 12(4):402-7. PubMed ID: 2203272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness.
    Sagebiel RW
    J Invest Dermatol; 1993 Mar; 100(3):322S-325S. PubMed ID: 8440914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic relationship between nevus count or nevus density and cutaneous malignant melanoma.
    Claus EB; Giuffra L; Rogers J; Risch N
    Cytogenet Cell Genet; 1992; 59(2-3):188-90. PubMed ID: 1737496
    [No Abstract]   [Full Text] [Related]  

  • 19. The dysplastic nevus syndrome. A pedigree with primary malignant melanomas of the choroid and skin.
    Albert DM; Chang MA; Lamping K; Weiter J; Sober A
    Ophthalmology; 1985 Dec; 92(12):1728-34. PubMed ID: 4088626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget.
    Qiu YQ; Yang CW; Lee YZ; Yang RB; Lee CH; Hsu HY; Chang CC; Lee SJ
    Oncotarget; 2019 Aug; 10(47):4919. PubMed ID: 31448057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.